Belong.Life, creators of the “Belong – Beating Cancer Together” mobile app, the world’s largest social network and navigator app for cancer patients, caregivers and healthcare professionals announced it has raised $14M in Series B funding led by IQVI. The Series B round also included participation from The Group Ventures and other existing investors.
Founded in 2015 by noted entrepreneurs Eliran Malki, Irad Deutsch and Ohad Rubin after each lost relatives to cancer, Belong – Beating Cancer Together is a free patient navigation app that allows cancer patients and their support network to explore and better manage their treatment journey while improving their quality of life.
The Belong global community of over 200k gains access to a proprietary big data platform and machine learning technology that enables people to connect, receive and share clinical information anonymously and to privately discuss issues related to their condition. The Belong Patient Engagement Platform provides healthcare organizations with an end-to-end solution that includes personalized and configurable patient engagement tools, navigation and management services.
Recent Traction/Milestones to Date
Today, Belong is the world’s largest digital cancer patient platform and has partnerships with leading patient advocacy associations, including the American Cancer Society, GO2 Foundation for Lung Cancer, Colorectal Cancer Canada, as well as many healthcare providers and pharma companies. The company also conducts research, collaborates with leading universities and has published research with The American Society of Clinical Oncology (ASCO) and other organizations.
Advancing Belong’s Patient Engagement Platform
The Series B funding will be used to expand this platform in addition to advancing the Belong’s new Patient Engagement Platform (PEP), which provides hospitals, pharma, payers and patient advocacy groups with tools for improved patient engagement, across a wide range of diseases. The end-to-end solution provides patients, payers, providers, and life science companies with hyper-
“We are honored by the support and trust of IQVIA and our investors,” said Eliran Malki, co-founder and chief executive officer of Belong.Life. “We at Belong are focused on building the most robust, hyper-personalized and configurable patient engagement and research platform. Starting with Belong – beating cancer together, we quickly grew to become the world’s largest social network and patient navigator app for cancer, collaborating with leading and disruptive researchers and publications in the market. Now, in addition to increasing our global cancer reach, Belong will bring its capabilities and expertise to additional diseases and stakeholders, to achieve the vision we established at the very beginning.”